[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2009/61879,2009,A1Locationinpatent:Page/Pagecolumn113
[2]Qu,Hongchang;Gu,Xuyuan;Min,ByoungJ.;Liu,Zhihua;Hruby,VictorJ.[OrganicLetters,2006,vol.8,#19,p.4215-4218]
13075-38-2
1272758-05-0
17922-79-1
24787-89-1
78818-15-2
103478-12-2
64837-52-1 | 5-Chloro-1,3,4-thiadiazole-2-carboxamide | AA00EKTG | MFCD16659015
58537-09-0 | 3-[4-chloro-3-(trifluoromethyl)phenyl]prop-2-enoic acid | AA00EL4V | MFCD01631407
612511-84-9 | 5-(aMinoMethyl)-, ethyl ester, hydrochloride | AA00ELE8 | MFCD10698162
61809-40-3 | 2-Bromo-5-methoxy-4-methylbenzoic acid | AA00ELS9 | MFCD20921580
61172-66-5 | 2-{[(tert-Butoxy)carbonyl]amino}pent-4-ynoic acid | AA00ELZE | MFCD18207317
61960-95-0 | 1,2-Benzenediamine, 3-(1,1-dimethylethyl)- | AA00EO2D | MFCD18804681
62547-09-5 | 5-(N-(2-Chlorophenyl)sulfamoyl)-2-hydroxybenzoic acid | AA00EQKR | MFCD02696653
5806-10-0 | 9-Butyl-9h-fluoren-9-ol | AA00ES9Y | MFCD31652815
60135-71-9 | 5-(3,4-Dimethoxyphenyl)-1,3,4-oxadiazol-2-amine | AA00EV0D | MFCD00755404
62763-33-1 | 3-HYDROXY-1-PHENYLBUTAN-2-ONE | AA00EYJW | MFCD11041289